Not exactly correct. I suggest you speak with either the transfer agent or Gavin regarding this issue. This is why we have two options...This is a poisen pill to protect against both unwanted takeover and to stop a third party from gaining enough shares to control the company. However, provisions reside within the verbiage to pay off very well in the case of a "negociatiated sale when an offer unsolisited".
All Geert is doing is tring to pervent a third party compnay from making an early move.
None the less I beleive the point was that Geert has a vested interest if a sale falls under the provision....If I was Geert I would be doing my best to make sure the sale of the company falls within that sanario.
I agree.Nothing new to be revealed at the conference. However, the same group attends every conference. I would think they are sick of Geert re-hashing of MK..
This is not a 5yr investment by the way. We shall know by Q-4's end if MK will be successful or not. It's no secret Geert wants to sell 1yrs prior to an FDA decession. LEAPS also needs to have at least 3 indiacations in P-2 and the build out completed and generating revenue in order to gain maxium profit in the sale of the company.
Remember almost all of Geert's shares qualify for the shareholder protection plan.That means a sale in Mid 2014.